Drugs & Therapy Perspectives

, Volume 19, Issue 11, pp 1–4 | Cite as

Micronised purified flavonoid fraction: a phlebotropic agent that is useful in the treatment of chronic venous insufficiency and venous ulcer

Drugs and Profile Reports
  • 59 Downloads

Keywords

Varicose Vein Hesperidin Venous Ulcer Calf Circumference Chronic Venous Insufficiency 

Notes

References

  1. 1.
    Nicolaides AN. Investigation of chronic venous insufficiency; a consensus statement. Circulation 2000 Nov 14; 102: e126–63PubMedCrossRefGoogle Scholar
  2. 2.
    Italian College of Phlebology. Guidelines for the diagnosis and treatment of chronic venous insufficiency. Int Angiol 2001 Jun; 20 (2 Suppl. 2): 1–37Google Scholar
  3. 3.
    Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 2003; 63 (1): 71–100.PubMedCrossRefGoogle Scholar
  4. 4.
    Porter J. M., Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21 (4): 635–45.PubMedCrossRefGoogle Scholar
  5. 5.
    International Task Force. The management of chronic venous disorders of the leg: an evidence-based report. Phlebology 1999; 14 Suppl. 1: 1–126CrossRefGoogle Scholar
  6. 6.
    Coleridge Smith PD. The drug treatment of chronic venous insufficiency and venous ulceration. In: Gloviczki P, Yao JST, editors. Handbook of venous disorders: guidelines of the American Venous Forum. 2nd ed. London: Arnold, 2001: 309–21Google Scholar
  7. 7.
    Boada JN, Nazco GJ. Therapeutic effect of venotonics in chronic venous insufficiency: a meta-analysis. Clin Drug Invest 1999 Dec; 18 (6): 413–32.CrossRefGoogle Scholar
  8. 8.
    Les Laboratoires Servier. Daflon: product description [online]. Available from URL: http://www.servier.com/pro/phlebologie/daflon.asp [Accessed 2003 Jun 20]
  9. 9.
    Chassignolle J-F, Amiel M, Lanfranchi G, et al. Activité thérapeutique de Daflon 500 mg dans l’insuffisance veineuse fonctionnelle. J Int Med 1987; 99 Suppl.: 32–7Google Scholar
  10. 10.
    Gilly R, Pillion G, Frileux C. Evaluation of a new venoactive micronized flavonoid fraction (S 5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: a double-blind, placebo-controlled study. Phlebology 1994; 9 (2): 67–70.Google Scholar
  11. 11.
    Cospite M, Dominici A. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Int Angiol 1989; 8 (4 Suppl.): 61–5PubMedGoogle Scholar
  12. 12.
    Jantet G. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids. Angiology 2002; 53 (3): 245–56.PubMedCrossRefGoogle Scholar
  13. 13.
    Guillot B, Guilhou JJ, de Champvallins M, et al. A long term treatment with a venotropic drug: results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency. Int Angiol 1989; 8 (4 Suppl.): 67–71PubMedGoogle Scholar
  14. 14.
    Guilhou J-J, Février F, Debure C, et al. Benefit of a 2-month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing: a randomized, double-blind, controlled versus placebo trial. Int J Microcirc Clin Exp 1997; 17 Suppl. 1: 21–6PubMedCrossRefGoogle Scholar
  15. 15.
    Gliñski W, Chodynicka B, Roszkiewicz J, et al. The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF) on the healing of leg ulcers: an open, multicentre, controlled, randomised study. Phlebology 1999; 14 (4): 151–7.CrossRefGoogle Scholar
  16. 16.
    Valencia IC, Falabella A, Kirsner RS, et al. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001; 44 (3): 401–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Meyer O. Safety of use of Daflon 500 mg confirmed by acquired experience and new research. Phlebology 1992; 7 Suppl. 2: 64–8Google Scholar

Copyright information

© Adis Data Information BV 2003

Personalised recommendations